Subheading: A technology-driven service provider combines gold-standard accuracy with long-read capability to tackle challenging sequences.
For Immediate Release – Researchers grappling with complex genomic regions, structural variations, or the need for full plasmid verification now have a powerful ally. Biosune, a sequencing service specialist, leverages a dual-platform strategy integrating Sanger sequencing and Nanopore long-read technology to deliver end-to-end solutions from routine validation to de novo analysis of challenging templates.
Precision Meets Length: The Two-Pillar Technology Strategy
Biosune’s core strength lies in its complementary technology portfolio. Its Sanger sequencing service remains the industry benchmark for applications requiring utmost base-by-base accuracy (>99.99%), such as PCR product verification, plasmid construct confirmation, and SNP analysis. In parallel, its Nanopore sequencing service offers true single-molecule, real-time long-read capability. This amplification-free technology sequences native DNA/RNA, generating reads spanning tens of kilobases, which is ideal for resolving structural variants, sequencing full-length plasmids, and deciphering high-GC or highly repetitive regions that are problematic for short-read technologies.
Guidance for the Right Tool: Matching Technology to Application
To help researchers select the optimal approach, Biosune provides clear guidance based on extensive project experience. For projects involving full plasmid sequencing, low-frequency variant detection, or complex amplicons, Nanopore sequencing offers a cost-effective and comprehensive solution. For routine clone screening or validation of short constructs, Sanger sequencing provides speed and precision. The company also publishes detailed sample submission guidelines (e.g., PCR products ≥20 ng/μL, avoidance of UV exposure) to ensure optimal data quality from the start.
Operational Excellence: Scale, Speed, and Quality Assurance
Biosune’s reliability is built on a robust operational backbone. The company operates multiple laboratories across China, supported by nearly 30 high-capacity sequencers, enabling a daily throughput of up to 30,000 reactions. This infrastructure allows for rapid turnaround, with the fastest delivery in as little as 10 hours for urgent projects. Quality is ingrained at every level: Biosune is certified under both ISO 9001 (Quality Management) and ISO 13485 (Medical Devices) standards. Its customer-centric support system includes free re-runs for anomalous Sanger results and multi-channel technical assistance.
About Biosune
Biosune specializes in providing high-precision, reliable DNA sequencing services to the global life science research community. With a founding team possessing over 30 years of expertise and a commitment to technological innovation, Biosune has served more than 30,000 clients, empowering research from basic science to applied diagnostics.